logo

For the Inventor, By the Inventor

Aichi, Japan

Kenji Kawamura

This inventor holds 5 USPTO granted patents. Top assignee: Banyu Pharmaceutical Co. Ltd. Active years: 1991-1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kenji Kawamura. Retrieved from https://idiyas.com/inventor/kenji-kawamura-doz78exq

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 5

% Patents Active = 100.0

Average Co-Inventor Count = 5.5

ph-index = 2

Forward Citations = 15(Granted Patents)


Location History:

  • Aichi, JP (1991 - 1994)
  • Isukuba, JP (1999)

Company Filing History:

goldMedal5 out of 237 
 
Banyu Pharmaceutical Co. Ltd
 patents

Years Active: 1991-1999

Loading Chart...
5 patents (USPTO):Explore Patents
1. 5928910 - Antifungal substances BE-49385 and process for their production (1999-07-27),
2. 5290698 - Streptoverticillium ferm P-10489 which produces antitumor agent BE-13793C (1994-03-01),
3. 5217885 - Antitumor substance BE-13793C (1993-06-08),
4. 5106864 - Antitumor substance BE-13793C (1992-04-21),
5. 5061695 - Antitumor substance BE-12406 (1991-10-29),

Title: Kenji Kawamura: Innovator in Antifungal and Antitumor Research

Introduction

Kenji Kawamura is a prominent inventor based in Aichi, Japan. He has made significant contributions to the fields of antifungal and antitumor research. With a total of 5 patents to his name, Kawamura has established himself as a key figure in pharmaceutical innovation.

Latest Patents

Kawamura's latest patents include groundbreaking work on antifungal substances, specifically BE-49385, and the process for their production. He has also developed a novel antitumor substance, BE-13793C, which is represented by a specific chemical formula. This substance is recognized for its potential as an anticancer agent, and it is accompanied by a method of production and a microorganism, Streptoverticillium FERM P-10489, capable of producing this novel substance.

Career Highlights

Throughout his career, Kawamura has been associated with Banyu Pharmaceutical Co. Ltd., where he has focused on developing innovative pharmaceutical solutions. His work has not only advanced scientific understanding but has also contributed to the development of new therapeutic agents.

Collaborations

Kawamura has collaborated with notable colleagues, including Hiroyuki Suda and Katuhisa Kojiri. These partnerships have fostered a collaborative environment that enhances research and development efforts in their field.

Conclusion

Kenji Kawamura's contributions to antifungal and antitumor research highlight his role as an influential inventor in the pharmaceutical industry. His innovative work continues to pave the way for new treatments and advancements in medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…